01—Abstract
Summary
Summary of the 10-Q filed June 7, 2024. Cited figures are marked; the original filing is the authoritative source.
Docusign, Inc. reported net income of $33.8 milliona for the three months ended April 30, 2024, compared with $0.5 million a year earlier, and income from operations of $22.6 million versus a loss of $4.7 million.
Total revenue was $709.6 millionb, up 7% from $661.4 million, driven by subscription revenue of $691.5 million (up 8%), which accounted for 97% of revenue in both periods. Total costs and expenses were $687.0 million, and restructuring and other related charges were $29.1 million, reflecting the 2025 Restructuring Plan. Net cash provided by operating activities was $254.8 million, and free cash flow, as defined by the company, was $232.1 million.
Balance sheet and capital allocation: cash, cash equivalents, restricted cash and investments totaled $1.2 billionc at quarter end, and the $500.0 million revolving credit facility had no outstanding borrowings. The company repurchased 2.5 million shares for $149.1 million during the quarter. Subsequent to quarter end, the board authorized up to $1.0 billion in additional repurchases, and the company acquired DocuSmart, Inc. d/b/a Lexion for approximately $165 million in cash, which closed on May 31, 2024.
Remaining performance obligations for contracts greater than one year were $2.2 billiond, with 56% expected to be recognized within 12 months. The filing also flags a potential tax benefit: the company believes it is reasonably possible that during fiscal 2025 sufficient positive evidence may emerge to release some or all of the U.S. valuation allowance, which would decrease income tax expense by an estimated $750 million to $850 million.
Ongoing litigation includes a securities class action (Weston v. Docusign, Inc.) that is proceeding, multiple shareholder derivative suits, and an arbitration brought by former CEO Daniel Springer, with a final arbitrator order expected on or before July 12, 2024.
02—Key points
Key Highlights
- Revenue of $709.6 million, up 7% year over year; subscription revenue of $691.5 million, up 8%, and 97% of total revenue.
- Operating income of $22.6 million versus an operating loss of $4.7 million in the prior-year period; net income of $33.8 million, or $0.16 per diluted share, versus $0.5 million in the prior year.
- Operating cash flow of $254.8 million and free cash flow of $232.1 million, as defined by the company.
- Cash, cash equivalents, restricted cash and investments of $1.2 billion at April 30, 2024, with no borrowings outstanding under the $500.0 million credit facility.
- Repurchased 2.5 million shares for $149.1 million; in May 2024 the board authorized an additional $1.0 billion repurchase program.
- Agreed to acquire Lexion, an AI-powered contract management platform, for approximately $165 million in cash; the acquisition closed on May 31, 2024.
- Potential release of the U.S. valuation allowance could reduce income tax expense by an estimated $750 million to $850 million in a period during fiscal 2025.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q1 FY2025, Docusign kept $0.05.
- Revenue$709.6M100.0%
- Cost of revenue−$149.4M21.1%
- Gross profit$560.2M78.9%
- Operating costs−$537.6M75.8%
- Operating income$22.6M3.2%
- Interest, other & tax$11.1M1.6%
- Net income$33.8M4.8%
04—Financials
Financial Highlights
Figures from 10-QQ1 FY2025filed June 7, 2024Financial Statements
Q1 FY2025 against Q1 FY2024
| Line item | Q1 FY2025Q1 FY2024 | Change |
|---|---|---|
| Revenue | $709.64M$661.39M | +7.3% |
| Cost of Revenue | $149.45M$136.49M | +9.5% |
| Gross Profit | $560.19M$524.90M | +6.7% |
| R&D Expenses | $134.32M$115.36M | +16.4% |
| Operating Expenses | $537.57M$529.55M | +1.5% |
| Operating Income | $22.63M-$4.65M | +586.5% |
| Interest Expense | $144K$1.97M | −92.7% |
| Net Income | $33.76M$539K | +6163.5% |
| EPS (Basic) | $0.16— | — |
| EPS (Diluted) | $0.16— | — |
| Shares Outstanding (Basic) | 205.87M202.63M | +1.6% |
| Shares Outstanding (Diluted) | 209.90M208.07M | +0.9% |
05—Questions
Frequently Asked Questions
How did Docusign's profitability change in the first quarter of fiscal 2025?
The company swung to operating income of $22.6 million from an operating loss of $4.7 million a year earlier, and net income rose to $33.8 million from $0.5 million. General and administrative expense fell $12.3 million, mainly due to lower stock-based compensation, while research and development expense rose $19.0 million.
What is the status of the potential tax benefit from the valuation allowance?
The company believes there is a reasonable possibility that during fiscal 2025 sufficient positive evidence may become available to release some or all of its U.S. valuation allowance. The filing estimates the release would decrease income tax expense by $750 million to $850 million, but the timing and amount depend on sustained U.S. profitability, stock price, and other factors.
What are the main legal risks disclosed?
A putative securities class action (Weston v. Docusign, Inc.) based on statements during the COVID-19 pandemic is proceeding after a motion to dismiss was denied in April 2023. Several shareholder derivative suits are pending, most stayed. A former CEO, Daniel Springer, is pursuing a JAMS arbitration alleging wrongful termination; the arbitration hearing took place in March 2024 and a final order is expected on or before July 12, 2024. The company believes the outcome of these matters will not have a material adverse effect.
How is the company returning capital to shareholders and funding acquisitions?
During the quarter, the company repurchased 2.5 million shares for $149.1 million at an average price of $58.78. In May 2024 the board authorized an additional $1.0 billion repurchase program with no minimum purchase commitment or end date. The Lexion acquisition, for about $165 million in cash, was funded from existing resources, with the company holding $1.2 billion in cash and investments at quarter end.
06—Continue